OCUL

Ocular Therapeutix (OCUL)

About Ocular Therapeutix (OCUL)

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Details

Daily high

$9.72

Daily low

$9.30

Price at open

$9.62

52 Week High

$16.44

52 Week Low

$6.23

Market cap

2.1B

Dividend yield

0.00%

Volume

99,539

Avg. volume

2.9M

P/E ratio

-6.65

Ocular Therapeutix News